Wellmedr vs HumeCare+ — Price, Protocol, and Promises

Wellmedr vs HumeCare+ compares two telehealth GLP-1 options that share compounded medication delivery but differ in price, care model, and guarantees. Quick verdict: Wellmedr is the lower-cost, bare-medication option with lifetime locked-in pricing and an aggressive money-back claim; HumeCare+ is the higher-cost protocol that bundles supportive ingredients, body-composition scans, and a 10%-or-money-back promise.

See Wellmedr plans starting at $89/mo

Wellmedr vs HumeCare+: key differences in one line

The most distinctive differences are starting price and pricing model, whether support ingredients and scans are included, the form of a money-back promise, clinician access and app features, and the shared regulatory note about compounded medications. Each is supported by the providers statements captured on their landing pages.

Price and pricing model

Wellmedr advertises GLP-1 plans starting at $89 per month for tirzepatide and as low as $49 a month on 12-month semaglutide plans during promotions, plus lifetime locked-in pricing and no dose-based price increases. HumeCare+ lists compounded semaglutide from $199 per month and a tirzepatide protocol from $299 per month, presented as a bundled program. The two options therefore split on lowest monthly cost versus a bundled service model.

CTA for HumeCare+

Explore HumeCare+ protocols from $199/mo

What you get: bare medication versus a bundled protocol

Wellmedr emphasizes GLP-1 medication plans with features like same-day review, free overnight shipping, and lifetime locked-in pricing. HumeCare+ positions itself as a protocol, not just a prescription, combining physician-prescribed compounded GLP-1 medication with glycine, vitamins B6 and B12, monthly body-composition scans, and an app for tracking. HumeCare+ frames these additions as muscle-preserving and side-effect relief supports that are not sold separately.

Money-back claims and outcome framing

Wellmedr markets a money-back guarantee claiming 100% refund if you don’t lose weight in 90 days and several promotional lock-in statements. HumeCare+ offers a 10%-or-money-back promise over six months, with terms to verify. Both providers qualify results as variable and tie treatment availability to clinician review.

Care access, tracking, and clinician support

HumeCare+ highlights unlimited clinician access, a U.S. care team available 24/7, a connected app for medication tracking and food logging, and monthly body-composition scans that report lean versus fat mass. Wellmedr emphasizes same-day clinician review and guaranteed on-time refills with discreet shipping, but landing-page evidence does not describe an app, body-composition scans, or 24/7 clinician access.

Regulatory and safety notes both providers share

Both Wellmedr and HumeCare+ offer compounded GLP-1 medications dispensed from U.S. pharmacies licensed by state Boards of Pharmacy. Both sources state that compounded medications are not evaluated by the FDA for safety, effectiveness, or quality and note GLP-1 medications may carry risks including thyroid C-cell tumors and medullary thyroid carcinoma. Each provider says treatment requires clinician evaluation and approval and that individual results vary.

Comparison table

Practical trade offs

If your priority is the lowest advertised monthly cost and lifetime locked-in pricing, Wellmedr is positioned for that need. If you value a bundled clinical protocol with muscle-preserving ingredients, body-composition scans, an app, and ongoing clinician optimization, HumeCare+ is designed for that approach but at higher monthly pricing.

Lock in Wellmedr pricing and plan details

View HumeCare+ protocol and terms

Compare Wellmedr plan features now

Choose one if…

Choose Wellmedr if you prioritize lower starting cost, lifetime locked-in pricing, no dose-based price increases, and same-day review with overnight shipping as advertised. Choose HumeCare+ if you want a bundled protocol that includes glycine and B vitamins for muscle support, monthly body-composition scans, a connected app, and the 10%-or-money-back promise with ongoing clinician optimization.

Both providers require clinician review and state compounded medications are not reviewed by the FDA for safety, effectiveness, or quality. Verify eligibility, full terms, and state availability directly with each provider before enrolling.